GlaxoSmithKline — Clinical Trial Pipeline

GlaxoSmithKline has 13 registered trials in the index.

Trials (13)

• First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors Phase 2 · GlaxoSmithKline
• Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Phase 3 · GlaxoSmithKline
• Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM Phase 1/2 · GlaxoSmithKline
• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor Phase 3 · GlaxoSmithKline
• A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) Phase 1/2 · GlaxoSmithKline
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy Phase 2 · GlaxoSmithKline
• Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM Phase 1/2 · GlaxoSmithKline
• Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1 Phase 2 · GlaxoSmithKline
• HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab Phase 2 · GlaxoSmithKline
• Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer Phase 2 · GlaxoSmithKline
• Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination N/A · GlaxoSmithKline
• PET Study to Study Tumour Apoptosis Phase 2 · GlaxoSmithKline
• Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists Phase 2 · GlaxoSmithKline

Related landscapes

• Infections, Papillomavirus
• Multiple Myeloma
• Cancer
• Neoplasms, Pancreatic
• Melanoma

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.